000661 长春高新
已收盘 11-13 15:00:00
资讯
新帖
简况
股市必读：长春高新新发布《关于子公司GenSci161注射液境内生产药品注册临床试验申请获得批准的公告》
证券之星 · 11-13 03:10
股市必读：长春高新新发布《关于子公司GenSci161注射液境内生产药品注册临床试验申请获得批准的公告》
长春高新：股权激励的核心目的就是为了充分调动公司控股子公司金赛药业核心管理、技术及业务骨干的工作积极性
证券之星 · 11-11 22:27
长春高新：股权激励的核心目的就是为了充分调动公司控股子公司金赛药业核心管理、技术及业务骨干的工作积极性
长春高新：公司始终高度重视市值管理工作
证券之星 · 11-11 22:24
长春高新：公司始终高度重视市值管理工作
长春高新：子公司GenSci161注射液新增CTD-ILD适应症临床试验获批
同花顺 · 11-11 18:28
长春高新：子公司GenSci161注射液新增CTD-ILD适应症临床试验获批
股市必读：长春高新新发布《关于子公司GenSci117吸入用粉末境内生产药品注册临床试验申请获得受理的公告》
证券之星 · 11-06
股市必读：长春高新新发布《关于子公司GenSci117吸入用粉末境内生产药品注册临床试验申请获得受理的公告》
长春高新子公司GenSci117吸入用粉末临床试验申请获受理
同花顺 · 11-04
长春高新子公司GenSci117吸入用粉末临床试验申请获受理
股市必读：长春高新（000661）11月3日董秘有最新回复
证券之星 · 11-04
股市必读：长春高新（000661）11月3日董秘有最新回复
股市必读：长春高新三季报 - 第三季度单季净利润同比下降39.12%
证券之星 · 11-02
股市必读：长春高新三季报 - 第三季度单季净利润同比下降39.12%
长春高新（000661）披露2026年三季度报告，10月30日股价下跌2.3%
证券之星 · 10-30
长春高新（000661）披露2026年三季度报告，10月30日股价下跌2.3%
长春高新(000661)9月30日股东户数11.78万户，较上期减少9.5%
证券之星 · 10-30
长春高新(000661)9月30日股东户数11.78万户，较上期减少9.5%
长春高新：10月29日接受机构调研，包括知名机构彤源投资，聚鸣投资的多家机构参与
证券之星 · 10-30
长春高新：10月29日接受机构调研，包括知名机构彤源投资，聚鸣投资的多家机构参与
长春高新最新公告：前三季度净利润同比下降49.68%
证券之星 · 10-29
长春高新最新公告：前三季度净利润同比下降49.68%
长春高新：第十一届董事会第二十四次会议决议公告
同花顺 · 10-29
长春高新：第十一届董事会第二十四次会议决议公告
股市必读：10月28日长春高新发生1笔大宗交易 成交金额242.93万元
证券之星 · 10-29
股市必读：10月28日长春高新发生1笔大宗交易 成交金额242.93万元
长春高新：子公司注射用GenSci136 境内生产药品注册临床试验申请获得批准
格隆汇 · 10-27
长春高新：子公司注射用GenSci136 境内生产药品注册临床试验申请获得批准
股市必读：长春高新新发布《关于2026年限制性股票激励计划预留授予登记完成的公告》
证券之星 · 10-26
股市必读：长春高新新发布《关于2026年限制性股票激励计划预留授予登记完成的公告》
10月23日长春高新涨5.40%，生物医药ETF国泰基金重仓该股
证券之星 · 10-23
10月23日长春高新涨5.40%，生物医药ETF国泰基金重仓该股
长春高新：公司以AI技术创新为企业战略跃迁的核心驱动力
证券之星 · 10-20
长春高新：公司以AI技术创新为企业战略跃迁的核心驱动力
长春高新：子公司GenSci155注射液临床试验申请获受理
同花顺 · 10-20
长春高新：子公司GenSci155注射液临床试验申请获受理
股市必读：长春高新新发布《关于子公司GenSci161注射液境内生产药品注册临床试验申请获得受理的公告》
证券之星 · 10-15
股市必读：长春高新新发布《关于子公司GenSci161注射液境内生产药品注册临床试验申请获得受理的公告》
加载更多
公司概况
公司名称：
长春高新技术产业(集团)股份有限公司
所属行业：
医药制造业
上市日期：
1996-12-18
主营业务：
长春高新技术产业(集团)股份有限公司的主营业务是生物制药及中成药的研发、生产和销售。公司的主要产品是生长激素系列产品、促卵泡激素系列、金蓓欣（伏欣奇拜单抗）、美适亚（醋酸甲地孕酮）、安脱达（屋尘螨变应原制剂）等。
发行价格：
8.80
{"stockData":{"symbol":"000661","market":"SZ","secType":"STK","nameCN":"长春高新","latestPrice":70.44,"timestamp":1794553425000,"preClose":71.03,"halted":0,"volume":4515559,"delay":0,"changeRate":-0.0083,"floatShares":394000000,"shares":408000000,"eps":-1.0389,"marketStatus":"已收盘","change":-0.59,"latestTime":"11-13 15:00:00","open":70.99,"high":72.49,"low":70.3,"amount":322000000,"amplitude":0.0308,"askPrice":70.45,"askSize":3,"bidPrice":70.44,"bidSize":15,"shortable":0,"etf":0,"ttmEps":-1.0389,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1794792600000},"marketStatusCode":5,"adr":0,"adjPreClose":71.03,"symbolType":"stock","openAndCloseTimeList":[[1794533400000,1794540600000],[1794546000000,1794553200000]],"highLimit":78.13,"lowLimit":63.93,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":407937529,"isCdr":false,"pbRate":1.29,"roa":"--","roe":"2.62%","epsLYR":0.39,"committee":0.452055,"marketValue":28735000000,"turnoverRate":0.0115,"status":1,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-11-16。","floatMarketCap":27779000000},"requestUrl":"/m/hq/s/000661","defaultTab":"news","newsList":[{"id":"2683511239","title":"股市必读：长春高新新发布《关于子公司GenSci161注射液境内生产药品注册临床试验申请获得批准的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2683511239","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2683511239?lang=zh_cn&edition=full","pubTime":"2026-11-13 03:10","pubTimestamp":1794510624,"startTime":"0","endTime":"0","summary":"公司公告汇总关于子公司GenSci161注射液境内生产药品注册临床试验申请获得批准的公告长春高新控股子公司长春金赛药业有限责任公司收到国家药监局核准签发的《药物临床试验批准通知书》，GenSci161注射液境内生产药品注册临床试验申请获批准，同意开展结缔组织病相关间质性肺疾病适应症的临床试验。该药此前已获准开展子宫内膜异位症、中重度化脓性汗腺炎、非感染性葡萄膜炎等适应症临床试验，并获美国FDA批准开展化脓性汗腺炎临床试验。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111300002783.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0075","BK0046","BK0188","BK0028","BK0057","000661"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682000833","title":"长春高新：股权激励的核心目的就是为了充分调动公司控股子公司金赛药业核心管理、技术及业务骨干的工作积极性","url":"https://stock-news.laohu8.com/highlight/detail?id=2682000833","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682000833?lang=zh_cn&edition=full","pubTime":"2026-11-11 22:27","pubTimestamp":1794407237,"startTime":"0","endTime":"0","summary":"公司推出股权激励，对应的考核指标是否能约束管理团队、倒逼经营改善，保障中小股东利益？","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111100046255.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0057","000661","BK0188","BK0075","BK0239","BK0028","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682300031","title":"长春高新：公司始终高度重视市值管理工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2682300031","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682300031?lang=zh_cn&edition=full","pubTime":"2026-11-11 22:24","pubTimestamp":1794407060,"startTime":"0","endTime":"0","summary":"新品获批不主动披露，投资者提问常常得不到回应，股价长期低迷。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111100046215.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0075","BK0239","BK0057","BK0028","BK0188","000661"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682303391","title":"长春高新：子公司GenSci161注射液新增CTD-ILD适应症临床试验获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2682303391","media":"同花顺","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682303391?lang=zh_cn&edition=full","pubTime":"2026-11-11 18:28","pubTimestamp":1794392880,"startTime":"0","endTime":"0","summary":"11月11日，长春高新(000661.SZ)公告，公司控股子公司金赛药业收到国家药品监督管理局核准签发的《药物临床试验批准通知书》，其GenSci161注射液境内生产药品注册临床试验申请获得批准，同意 ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20261111/c681716780.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20261111/c681716780.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["IBBJ","BK0046","IBBQ","MDTX","BMED","PSYK","BK0075","000661","BK0188","BK0239","BK0057","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681400309","title":"股市必读：长春高新新发布《关于子公司GenSci117吸入用粉末境内生产药品注册临床试验申请获得受理的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2681400309","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681400309?lang=zh_cn&edition=full","pubTime":"2026-11-06 01:41","pubTimestamp":1793900468,"startTime":"0","endTime":"0","summary":"截至2026年11月5日收盘，长春高新报收于74.5元，上涨1.78%，换手率1.43%，成交量5.65万手，成交额4.19亿元。当日关注点交易信息汇总：11月5日主力资金净流入735.07万元，占总成交额1.76%。公司公告汇总：子公司金赛药业自主研发的GenSci117吸入用粉末境内临床试验申请获国家药监局受理，拟用于治疗特发性肺纤维化。该药品为化药1类创新药，拟用于治疗特发性肺纤维化，采用吸入给药方式，通过GPODS平台递送siRNA，靶向抑制MMP7表达。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110600001938.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0075","BK0046","BK0057","BK0028","BK0188","BK0239","000661"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680052886","title":"长春高新子公司GenSci117吸入用粉末临床试验申请获受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2680052886","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680052886?lang=zh_cn&edition=full","pubTime":"2026-11-04 21:37","pubTimestamp":1793799420,"startTime":"0","endTime":"0","summary":"上证报中国证券网讯(记者田甜)长春高新11月4日晚发布公告称，公司控股子公司金赛药业收到国家药品监督管理局核准签发的《受理通知书》，GenSci117吸入用粉末的境内生产药品注册临床试验申请 ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20261104/c681475720.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20261104/c681475720.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["BK0075","BK0028","IBBJ","BMED","BK0057","PSYK","000661","BK0046","BK0188","BK0239","IBBQ","MDTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680776822","title":"股市必读：长春高新（000661）11月3日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2680776822","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680776822?lang=zh_cn&edition=full","pubTime":"2026-11-04 01:29","pubTimestamp":1793726971,"startTime":"0","endTime":"0","summary":"截至2026年11月3日收盘，长春高新报收于71.69元，下跌1.52%，换手率1.22%，成交量4.81万手，成交额3.47亿元。董秘最新回复投资者： 董秘，这个业绩这个营收，怎么完成激励目标？当日关注点交易信息汇总：11月3日主力资金净流出1611.77万元，占总成交额4.65%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110400002778.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0057","BK0239","BK0075","000661","BK0188","BK0028","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680207777","title":"股市必读：长春高新三季报 - 第三季度单季净利润同比下降39.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2680207777","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680207777?lang=zh_cn&edition=full","pubTime":"2026-11-02 03:52","pubTimestamp":1793562730,"startTime":"0","endTime":"0","summary":"公司公告汇总：公司于2026年10月28日董事会审议通过第三季度计提资产减值准备4683.06万元，其中存货减值2882.76万元占比最高。业绩披露要点财务报告2026年前三季度主营收入82.51亿元，同比下降15.86%；归母净利润5.86亿元，同比下降49.68%；扣非净利润6.87亿元，同比下降45.84%。公司公告汇总2026年三季度报告2026年第三季度营业收入27.08亿元，同比下降15.46%；归母净利润1.11亿元，同比下降39.12%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110200000975.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000661"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679163512","title":"长春高新（000661）披露2026年三季度报告，10月30日股价下跌2.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679163512","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679163512?lang=zh_cn&edition=full","pubTime":"2026-10-30 19:43","pubTimestamp":1793360583,"startTime":"0","endTime":"0","summary":"截至2026年10月30日收盘，长春高新报收于69.69元，较前一交易日下跌2.3%，最新总市值为284.29亿元。公司于2026年10月30日披露《2026年三季度报告》。报告显示，本报告期营业收入2,708,331,673.54元，比上年同期下降15.46%；归属于上市公司股东的净利润110,801,398.02元，同比下降39.12%。年初至报告期末，公司实现营业收入8,251,043,700.68元，同比下降15.86%；归属于上市公司股东的净利润586,124,281.63元，同比下降49.68%；扣除非经常性损益后的净利润687,174,500.99元，同比下降45.84%。基本每股收益1.46元，同比下降49.66%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000048798.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","000661","BK0188","BK0075","BK0239","BK0057","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679213967","title":"长春高新(000661)9月30日股东户数11.78万户，较上期减少9.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679213967","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679213967?lang=zh_cn&edition=full","pubTime":"2026-10-30 19:16","pubTimestamp":1793359008,"startTime":"0","endTime":"0","summary":"证券之星消息，近日长春高新披露，截至2026年9月30日公司股东户数为11.78万户，较6月30日减少1.24万户，减幅为9.5%。在生物制品行业个股中，长春高新股东户数高于行业平均水平，截至9月30日，生物制品行业平均股东户数为3.67万户。从股价来看，2026年6月30日至2026年9月30日，长春高新区间涨幅为7.85%，在此期间股东户数减少1.24万户，减幅为9.5%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000047137.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0046","BK0057","BK0239","BK0075","000661","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679835268","title":"长春高新：10月29日接受机构调研，包括知名机构彤源投资，聚鸣投资的多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2679835268","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679835268?lang=zh_cn&edition=full","pubTime":"2026-10-30 12:03","pubTimestamp":1793332991,"startTime":"0","endTime":"0","summary":"若GenSci171最终获批上市，有望提升患者治疗依从性。该股最近90天内共有7家机构给出评级，买入评级5家，增持评级2家；过去90天内机构目标均价为102.77。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000026053.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0075","BK0188","BK0028","000661","BK0239","BK0057","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679284678","title":"长春高新最新公告：前三季度净利润同比下降49.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679284678","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679284678?lang=zh_cn&edition=full","pubTime":"2026-10-29 23:49","pubTimestamp":1793288989,"startTime":"0","endTime":"0","summary":"长春高新(000661.SZ)公告称，第三季度营业收入为27.08亿元，同比下降15.46%；归属于上市公司股东的净利润为1.11亿元，同比下降39.12%。前三季度实现营业收入82.51亿元，同比下降15.86%；归属于上市公司股东的净利润5.86亿元，同比下降49.68%。注：公司Q3净利润1.11亿，Q2净利润2亿，据此计算，Q3净利润环比下降44%。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102900064984.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000661"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679971283","title":"长春高新：第十一届董事会第二十四次会议决议公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2679971283","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679971283?lang=zh_cn&edition=full","pubTime":"2026-10-29 21:31","pubTimestamp":1793280660,"startTime":"0","endTime":"0","summary":" 证券日报网讯 10月29日，长春高新发布公告称，公司于2026年10月28日召开第十一届董事会第二十四次会议，审议通过《2026年第三季度报告》《关于2026年第三季度 ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20261029/c681260258.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20261029/c681260258.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["BK0188","000661","BK0239","BK0046","BK0057","BK0075","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679419321","title":"股市必读：10月28日长春高新发生1笔大宗交易 成交金额242.93万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2679419321","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679419321?lang=zh_cn&edition=full","pubTime":"2026-10-29 04:07","pubTimestamp":1793218058,"startTime":"0","endTime":"0","summary":"截至2026年10月28日收盘，长春高新报收于71.66元，下跌0.22%，换手率1.12%，成交量4.4万手，成交额3.16亿元。当日关注点交易信息汇总：10月28日主力资金净流出1073.44万元，占总成交额3.39%； 交易信息汇总：当日发生1笔大宗交易，成交金额242.93万元。大宗交易10月28日长春高新发生1笔大宗交易，成交金额242.93万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102900004209.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0075","BK0046","BK0057","BK0028","BK0188","BK0239","000661"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678120053","title":"长春高新：子公司注射用GenSci136 境内生产药品注册临床试验申请获得批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2678120053","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678120053?lang=zh_cn&edition=full","pubTime":"2026-10-27 18:10","pubTimestamp":1793095839,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0075","000661","BK0239","BK0028","BK0046","BK0188","BK0057"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678352231","title":"股市必读：长春高新新发布《关于2026年限制性股票激励计划预留授予登记完成的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2678352231","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678352231?lang=zh_cn&edition=full","pubTime":"2026-10-26 01:10","pubTimestamp":1792948221,"startTime":"0","endTime":"0","summary":"截至2026年10月23日收盘，长春高新报收于72.08元，上涨5.4%，换手率1.72%，成交量6.81万手，成交额4.79亿元。公司公告汇总：长春高新完成2026年限制性股票激励计划预留授予登记，授予数量41.00万股，授予价格38.08元/股，激励对象为金赛药业核心骨干共19人。公司公告汇总关于2026年限制性股票激励计划预留授予登记完成的公告长春高新完成2026年限制性股票激励计划预留授予登记，授予日为2026年9月29日，登记完成日为2026年10月23日。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102600000385.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0057","BK0239","BK0075","000661","BK0188","BK0028","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677944241","title":"10月23日长春高新涨5.40%，生物医药ETF国泰基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2677944241","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677944241?lang=zh_cn&edition=full","pubTime":"2026-10-23 16:44","pubTimestamp":1792745052,"startTime":"0","endTime":"0","summary":"证券之星消息，10月23日长春高新涨5.40%创60日新低，收盘报72.08元，换手率1.72%，成交量6.81万手，成交额4.79亿元。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共13家，其中持有数量最多的公募基金为国泰基金的生物医药ETF国泰。生物医药ETF国泰的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102300030449.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0046","BK0057","BK0239","BK0075","000661","512290","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676695767","title":"长春高新：公司以AI技术创新为企业战略跃迁的核心驱动力","url":"https://stock-news.laohu8.com/highlight/detail?id=2676695767","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676695767?lang=zh_cn&edition=full","pubTime":"2026-10-20 20:48","pubTimestamp":1792500497,"startTime":"0","endTime":"0","summary":"长春高新回复：您好，公司2026 年半年度报告中有AI技术应用的相关披露内容，具体如下：公司以AI技术创新为企业战略跃迁的核心驱动力，紧密围绕市场需求与临床应用价值，系统地将AI技术应用于研发、流程优化及企业级数字平台，以提升效率并支持创新，已在AI药物发现、大模型设计蛋白、临床研究设计等领域取得实质性突破。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102000034306.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0075","BK0028","BK0057","000661","BK0046","BK0188","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676664274","title":"长春高新：子公司GenSci155注射液临床试验申请获受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2676664274","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676664274?lang=zh_cn&edition=full","pubTime":"2026-10-20 18:11","pubTimestamp":1792491060,"startTime":"0","endTime":"0","summary":"每经AI快讯，10月20日，长春高新(000661.SZ)公告称，公司控股子公司金赛药业收到国家药监局核准签发的《受理通知书》，GenSci155注射液境内生产药品注册临床试验申请获得受理。该药品为自主 ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20261020/c680893602.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20261020/c680893602.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["BK0239","BK0057","BK0075","BMED","BK0046","IBBJ","IBBQ","MDTX","PSYK","000661","BK0028","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675213403","title":"股市必读：长春高新新发布《关于子公司GenSci161注射液境内生产药品注册临床试验申请获得受理的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2675213403","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675213403?lang=zh_cn&edition=full","pubTime":"2026-10-15 02:11","pubTimestamp":1792001469,"startTime":"0","endTime":"0","summary":"公司公告汇总关于子公司GenSci161注射液境内生产药品注册临床试验申请获得受理的公告长春高新控股子公司金赛药业收到国家药品监督管理局签发的《受理通知书》，其自主研发的GenSci161注射液用于复发性心包炎的境内生产药品注册临床试验申请已获受理。该药品为新型全人源单克隆IgG1双特异性抗体，可同时靶向IL-1α和IL-1β。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101500001774.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0075","BK0188","BK0057","BK0028","BK0239","000661"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1794605880796,"stockEarnings":[{"period":"1week","weight":-0.0451},{"period":"1month","weight":0.0014},{"period":"3month","weight":-0.1673},{"period":"6month","weight":-0.1612},{"period":"1year","weight":-0.3243},{"period":"ytd","weight":-0.2374}],"compareEarnings":[{"period":"1week","weight":-0.0041},{"period":"1month","weight":-0.0353},{"period":"3month","weight":-0.0746},{"period":"6month","weight":-0.1212},{"period":"1year","weight":-0.0981},{"period":"ytd","weight":-0.0843}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"长春高新技术产业(集团)股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"117779人(较上一季度减少9.50%)","perCapita":"3348股","listingDate":"1996-12-18","address":"吉林省长春市朝阳区高新区海容酒店及海茵广场写字楼B座2708室","registeredCapital":"40793万元","survey":" 长春高新技术产业(集团)股份有限公司的主营业务是生物制药及中成药的研发、生产和销售。公司的主要产品是生长激素系列产品、促卵泡激素系列、金蓓欣（伏欣奇拜单抗）、美适亚（醋酸甲地孕酮）、安脱达（屋尘螨变应原制剂）等。","listedPrice":8.8},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"长春高新(000661)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供长春高新(000661)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"长春高新,000661,长春高新股票,长春高新股票老虎,长春高新股票老虎国际,长春高新行情,长春高新股票行情,长春高新股价,长春高新股市,长春高新股票价格,长春高新股票交易,长春高新股票购买,长春高新股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"长春高新(000661)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供长春高新(000661)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}